IDEXX Laboratories Ownership
| IDXX Stock | USD 421.75 0.01 0% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 83.4 M | Current Value 83.1 M | Avarage Shares Outstanding 116.9 M | Quarterly Volatility 25.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
IDEXX |
IDEXX Stock Ownership Analysis
About 94.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 10.38. IDEXX Laboratories had not issued any dividends in recent years. The entity had 2:1 split on the 16th of June 2015. IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Idexx Laboratories operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 10000 people. To learn more about IDEXX Laboratories call Jonathan Mazelsky at 207 556 0300 or check out https://www.idexx.com.Besides selling stocks to institutional investors, IDEXX Laboratories also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different IDEXX Laboratories' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align IDEXX Laboratories' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
IDEXX Laboratories Quarterly Liabilities And Stockholders Equity |
|
IDEXX Laboratories Insider Trades History
Less than 1% of IDEXX Laboratories are currently held by insiders. Unlike IDEXX Laboratories' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against IDEXX Laboratories' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of IDEXX Laboratories' insider trades
IDEXX Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IDEXX Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IDEXX Laboratories backward and forwards among themselves. IDEXX Laboratories' institutional investor refers to the entity that pools money to purchase IDEXX Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blair William & Co | 2024-06-30 | 1.2 M | Brown Advisory Holdings Inc | 2024-09-30 | 1.1 M | Norges Bank | 2024-06-30 | 994.4 K | Fundsmith Investment Services Ltd. | 2024-09-30 | 865 K | Goldman Sachs Group Inc | 2024-06-30 | 815.4 K | Legal & General Group Plc | 2024-06-30 | 777.3 K | Northern Trust Corp | 2024-09-30 | 769.5 K | Jpmorgan Chase & Co | 2024-06-30 | 756.2 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 751.9 K | Vanguard Group Inc | 2024-09-30 | 9.7 M | Blackrock Inc | 2024-06-30 | 9.6 M |
IDEXX Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IDEXX Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on IDEXX Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IDEXX Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IDEXX Laboratories' latest congressional trading
Congressional trading in companies like IDEXX Laboratories, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in IDEXX Laboratories by those in governmental positions are based on the same information available to the general public.
| 2024-02-14 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2024-02-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify |
IDEXX Laboratories Outstanding Bonds
IDEXX Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. IDEXX Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IDEXX bonds can be classified according to their maturity, which is the date when IDEXX Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| IEX 2625 15 JUN 31 Corp BondUS45167RAH75 | View | |
| US45167RAG92 Corp BondUS45167RAG92 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
IDEXX Laboratories Corporate Filings
F4 | 29th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 31st of May 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.